마약류 진통제 안전관리 방안 마련을 위한 설문연구

키워드

참고문헌 (57)

1. "Model list of essential medicines" (2021)[URL]
2. Yuh YJ, "Opioid Use in Pain", J Pain Auton Disord, 2(2), pp.84~88 (2013)
3. 심재용, "만성 비암성통증에서 마약성 진통제의 사용", 대한의사협회지, 56(8), pp.711~717 (2013), 대한의사협회
4. Naples JG, "The Role of Opioid Analgesics in Geriatric Pain Management", Clin Geriatr Med, 32(4), pp.725~735 (2016)
5. Esnaola NF, "Pain and quality of life after treatment in patients with locally recurrent rectal cancer", J Clin Oncol, 20(21), pp.4361~4367 (2002)
6. Noble M, "Long-term opioid management for chronic noncancer pain", The Cochrane database of systematic reviews, 2010(1), pp.Cd006605~ (2010)[DOI]
7. Schieber LZ, "Trends and Patterns of Geographic Variation in Opioid Prescribing Practices by State, United States, 2006-2017", JAMA Network Open, 2(3), pp.e190665~ (2019)
8. 윤지현, "Recent Trends in Opioid Prescription in Cancer Patients in Korea", Korean Journal of Family Practice, 11(2), pp.142~146 (2021), 대한가정의학회[DOI]
9. Pierce M, "Is Europe facing an opioid crisis like the United States? An analysis of opioid use and related adverse effects in 19 European countries between 2010 and 2018", European Psychiatry, 64(1), pp.e47~ (2021)
10. Unick GJ, "Intertwined epidemics : national demographic trends in hospitalizations for heroin-and opioid-related overdoses, 1993–2009", PLoS One, 8(2), pp.e54496~ (2013)
11. Cicero TJ, "Shifting patterns of prescription opioid and heroin abuse in the United States", The New England Journal of Medicine, 373(18), pp.1789~1790 (2015)
12. Lin H-C, "Associations between statewide prescription drug monitoring program(PDMP)requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain", Addictive Behaviors, 76, pp.348~354 (2018)
13. "Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use" (2017)[URL]
14. Schuchat A, "New data on opioid use and prescribing in the United States", JAMA, 318(5), pp.425~426 (2017)
15. Guy GP, Jr, "County-Level Opioid Prescribing in the United States, 2015 and 2017", JAMA Internal Medicine, 179(4), pp.574~576 (2019)
16. Schatman ME, "Pain management, prescription opioid mortality, and the CDC : is the devil in the data?", Journal of Pain Research, 10, pp.2489~2495 (2017)
17. "Public Awarness Report on the Seriousness of Narcotics 2016-2020"[URL]
18. Bednarczyk EM, "A large-scale, online, multiprofessional opioid prescriber training program", J Am Coll Clin Pharm, 5(2), pp.123~131 (2022)
19. Slovis BH, "Reduction in Hospital System Opioid Prescribing for Acute Pain Through Default Prescription Preference Settings : Pre-Post Study", J Med Internet Res, 23(4), pp.e24360~ (2021)
20. "The current status of drug abuse and policies to solve the problems" (2019)[URL]
21. 김현주, "의료기관의 마약성 진통제 사용 현황과관리에 대한 개선방안", 의생명과학과법, 26, pp.151~170 (2021), 법학연구소
22. 고세일, "아편유사제의 안전한 사용", 대한의사협회지, 65(1), pp.57~65 (2022), 대한의사협회[DOI]
23. Freund CR, "Opioid Prescription Trends in a US Dental School Clinic, 2014-2018 : A Retrospective Study Using Electronic Health Record Data", Journal of Public Health Managnagment & Practice, 28(1), pp.E264~E272 (2022)
24. "Maryland Public Opinion Survey on Opioids, 2019 Summary Report" (2019)[URL]
25. Chai G, "New Opioid Analgesic Approvals and Outpatient Utilization of Opioid Analgesics in the United States, 1997 through 2015", Anesthesiology, 128(5), pp.953~966 (2018)
26. "Pain management and the opioid epidemic: Balancing societal and individual benefits and risks of prescription opioid use" (2017)[URL]
27. Montioring the future national survey results on drug use, 1975-2020:2020 Overview Key findings on adolescent drug use, "Johnston LD", Institute for Social Research, University of Michigan, ~ (2021)
28. Volkow ND, "The changing opioid crisis : development, challenges and opportunities", Molecular Psychiatry, 26(1), pp.218~233 (2021)
29. Kim Joungyoun, "Recent trends in opioid prescriptions in Korea from 2002 to 2015 based on the Korean NHIS-NSC cohort", Epidemiology and Health, 44, pp.1~8 (2022), 한국역학회[DOI]
30. Cho NR, "Trends in opioid prescribing practices in South Korea, 2009–2019 : Are we safe from an opioid epidemic?", PLoS One, 16(5), pp.e0250972~ (2021)
31. 홍세리, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017", Cancer Research and Treatment, 52(2), pp.335~350 (2020), 대한암학회
32. Song I-A, "Long-term opioid use and mortality in patients with chronic non-cancer pain : Tenyear follow-up study in South Korea from 2010 through 2019", eClinicalMedicine, 51, pp.101558~ (2022)
33. 유명식, "마약류 통합관리시스템을 통한 의료용 마약류 관리", 대한내과학회지, 93(4), pp.313~316 (2018), 대한내과학회
34. "Notice on implementation of ‘Drug shopping prevention inforamtion network’" (2021)[URL]
35. "Notice on implementation of ‘Safety standards for medical psychotropic appetite suppressants" (2020)[URL]
36. "Notice on implementation of ‘Safety standards for Zolpidem and Propofol’" (2020)[URL]
37. "Notice on implementation of ‘Safety standards for prescription opioid and benzodiazepines’" (2021)[URL]
38. "Notice on implementation of ‘Safety standards for psychotropic ADHD medications and narcotic anti-tussives’" (2022)[URL]
39. "Timeline of Selected FDA Activities and Significant Events Addressing Substance Use and Overdose Prevention" (2023)[URL]
40. Zipple M, "Success of hospital intervention and state legislation on decreasing and standardizing postoperative opioid prescribing practices", Journal of the American College of Surgeons, 229(2), pp.158~163
41. Sears JM, "Opioid overdose hospitalization trajectories in states with and without opioid-dosing guidelines", Public Health Reports, 134(5), pp.567~576 (2019)
42. Chen Q, "Impact of an opioid safety initiative on patients undergoing total knee arthroplasty : a time series analysis", Anesthesiology, 131(2), pp.369~380 (2019)
43. Puac-Polanco V, "Prescription drug monitoring programs and prescription opioid–related outcomes in the United States", Epidemiologic Reviews, 42(1), pp.134~153 (2020)
44. Chen Q, "Prevention of prescription opioid misuse and projected overdose deaths in the United States", JAMA Network Open, 2(2), pp.e187621~ (2019)
45. "National Drug Control Strategy" (2022)[URL]
46. Dowell D, "CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022", MMWR Recomm Rep, 71, pp.1~95 (2022)
47. "The Survey of Metnal disorders in Korea 2016" (2017)[URL]
48. "The Survey of Drug Users in Korea 2021" (2022)[URL]
49. Gemenis K, "An iterative expert survey approach for estimating parties’ policy positions", Quality and Quantity, 49(6), pp.2291~2306 (2015)
50. Wucherpfennig F, "Towards a taxonomy of mechanisms of change? Findings from an expert survey on the association between common factors and specific techniques in psychotherapy", Psychotherapy Research, pp.1~14 (2023)
51. Faes L, "Overcoming barriers of retinal care delivery during a pandemic-attitudes and drivers for the implementation of digital health : a global expert survey", British Journal of Ophthalmology, 105(12), pp.1738~1743 (2021)
52. Rehm J, "Problematic drug use and drug use disorders in EU countries and Norway : An overview of the epidemiology", European Neuropsychopharmacology, 15(4), pp.389~397 (2005)
53. "The introduction of Narcotics Control Council"[URL]
54. "The government and the ruling party, organized a control tower in charge of substances management…operated a special investigation team for one year" (2022)[URL]
55. "Notice on establishment of ‘Comprehensive substances management measures’" (2022)[URL]
56. "Notice on major achievements and future plans of comprehensive substances management measures" (2023)[URL]
57. "The government and the ruling party, Discussing substances management measures… “A serious phase, but preventable”" (2023)[URL]

관련 논문AI추천